Answers are grounded in this paper and cite their sources.
Demonstrates saxagliptin's anti-cancer effects in lung adenocarcinoma cells, highlighting its therapeutic potential.
Conclusions: SAXA showed promising anti-cancer action against A549 cells. Although the combination with CP did not boost cytotoxicity, the observed pro-apoptotic reduction in BCL2 implies potential therapeutic efficacy.
No takes yet. Share an insight, caveat, or question.
Shubbar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: